Description

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States. The company focuses on producing controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. It offers Esterified Estrogen with Methyltestosterone for use in treating vasomotor symptoms of menopause; Etodolac used to treat pain caused by osteoarthritis, rheumatoid arthritis, and other conditions; Flecainide for treating arrhythmia; Fluvoxamine for use in treating obsessive-compulsive disorders and social anxiety disorders; Hydrocortisone Enema and Cortenema used to treat ulcerative colitis; and Methazolamide for treating ocular conditions. The company also provides Metoclopramide and Reglan for treating gastroesophageal reflux; Nimodipine that reduces the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage; Opium Tincture to treat diarrhea; Oxycodone oral solution, which relieves pain; Propafenone used to treat arrhythmia; Lithobid for treating the manic episodes of bipolar disorder; and Vancocin and Vancocin for use in treating C. difficile-associated diarrhea, as well as enterocolitis caused by staphylococcus aureus. In addition, it provides contract manufacturing services for other pharmaceutical companies. The company markets and sells its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. is headquartered in Baudette, Minnesota.